Exam 4 - STIs Jenkins (not done) Flashcards
(57 cards)
PrEP 3 drug options (brand names)
Truvada (F/TDF)
Descovy (F/TAF)
Apretude
Truvada components (2)
emtricitabine + tenofovir disoproxil fumarate
(F/TDF)
Descovy components (2)
emtricitabine + tenofovir alafenamide
(F/TAF)
Apretude active ingredient
cabotegravir
HPV vaccine is recommended for routine vaccination at age ___ or ___ (can be started at age ___). It is recommended for everyone through age ___ years if not completed when younger
11 or 12
9
26
Gonorrhea etiologic agent
Neisseria gonorrhoeae
epidemiology of neisseria gonorrhoeae: major cause of _____ _____ _____
pelvic inflammatory disease (PID)
standard of care for diagnosis of gonorrhoeae in urine, rectum, throat
a. gram stain
b. NAAT
c. culture
b. NAAT
preferred drug for uncomplicated gonococcal infections of the cervix, urethra, and rectum (not including doses)
ceftriaxone
drug that is tx of choice for all stages of syphilis
Pen G (parenteral)
T or F: people who are already using PrEP typically need PEP as well
F
nPEP preferred regimen (3 drug regimen)
tenofovir disoproxil fumarate +
emtricitabine +
raltegravir OR dolutegravir
x 28 days
(F/TDF + RAL or DTG)
nPEP alternative regimen
tenofovir disoproxil fumarate +
emtricitabine +
darunavir +
ritonavir
x 28 days
(F/TDF + DRV + RTV)
pharmacokinetic enhancer to inc trough conc and prolong half life of protease inhibitors
a. darunavir (DRV)
b. ritonavir (RTV)
c. raltegavir (RAL)
d. dolutegravir (DTG)
b. ritonavir (RTV)
second most common notifiable disease in the US
a. syphilis
b. gonorrhoeae
c. chlamydia
d. trichomoniasis
b. gonorrhoeae
tx of uncomplicated gonococcal infections of the cervix, urethra, and rectum:
< 150 kg
a. ceftriaxone 500 mg IM x 1
b. ceftriaxone 1 gm IM x 1
c. doxy 100 mg PO BID x 7 days
d. azithro 1 gm PO x 1
a. ceftriaxone 500 mg IM x 1
tx of uncomplicated gonococcal infections of the cervix, urethra, and rectum:
< 150 kg
chlamydia not excluded
not pregnant
a. ceftriaxone 500 mg IM x 1
b. ceftriaxone 1 gm IM x 1
c. doxy 100 mg PO BID x 7 days
d. azithro 1 gm PO x 1
c. doxy 100 mg PO BID x 7 days
tx of uncomplicated gonococcal infections of the cervix, urethra, and rectum:
150+ kg
a. ceftriaxone 500 mg IM x 1
b. ceftriaxone 1 gm IM x 1
c. doxy 100 mg PO BID x 7 days
d. azithro 1 gm PO x 1
b. ceftriaxone 1 gm IM x 1
tx of uncomplicated gonococcal infections of the cervix, urethra, and rectum:
150+ kg
chlamydia not excluded
not pregnant
a. ceftriaxone 500 mg IM x 1
b. ceftriaxone 1 gm IM x 1
c. doxy 100 mg PO BID x 7 days
d. azithro 1 gm PO x 1
c. doxy 100 mg PO BID x 7 days
tx option for PREGNANT uncomplicated gonococcal infection of the cervix, urethra, and rectum
a. ceftriaxone 500 mg IM x 1
b. ceftriaxone 1 gm IM x 1
c. doxy 100 mg PO BID x 7 days
d. azithro 1 gm PO x 1
d. azithro 1 gm PO x 1
tx of uncomplicated gonococcal infections of the cervix, urethra, and rectum: two options if ceftriaxone is NOT available
-genta + azithro
-cefixime
AC is a 32yof with a past medical history of asthma, non-insulin dependent type 2 diabetes, and obesity who presents to hospital with anal pruritis, bleeding, discharge, and pain. She has recently been newly sexually active with one new partner. Her partner does not always use a condom when they have sex. She is diagnosed with uncomplicated gonococcal infection of the rectum and ruled out chlamydia infection. She has no known drug allergies and is not pregnant. Weight 162kg
Which would be the best treatment option?
A.) Ceftriaxone 500 mg IM x1 dose
B.) Ceftriaxone 1000 mg IM x1 dose
C.) Gentamicin 240 mg IM x1 dose PLUS doxycycline 100mg PO BID x 7 days
D.) Ceftriaxone 1000 mg IM x1 dose PLUS azithromycin 1000 mg PO x 1 dose
B.) Ceftriaxone 1000 mg IM x1 dose
(a. is wrong dose; c is genta plus azithro; d. would be if they have chlamydia and pregnant)
syphilis etiologic agent
treponema pallidum
first line for primary and secondary syphilis
a. benzathine pen G
b. doxy
c. tetracyline
d. azithro
a. benzathine pen G
(the other 3 are if there is a PCN allergy)